Also trades as: 0809.HK (HKSE) · $vol 0M
GBCMY OTC
Global Bio-chem Technology Group Company Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -15.0%
1Y: -15.0%
3Y: -55.0%
$4.14
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$4.6B
+1.7% ▲
5Y CAGR: -9.5%
Total Liabilities
$5.1B
-20.9% ▼
5Y CAGR: -17.7%
Shareholders Equity
-$518M
+73.5% ▲
Cash & Investments
$94M
-36.8% ▼
5Y CAGR: -9.2%
Total Debt
$1.8B
-51.4% ▼
5Y CAGR: -27.5%
Net Debt
$1.7B
-52.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $22M | $42M | $88M | $85M | $94M |
| Short-Term Investments | $87M | $54M | $44M | $64M | $0 |
| Cash & ST Investments | $109M | $96M | $315M | $149M | $94M |
| Net Receivables | $443M | $279M | $396M | $1.7B | $2.0B |
| Inventory | $81M | $217M | $148M | $206M | $45M |
| Other Current Assets | -$87M | $173K | $45M | $0 | $42M |
| Total Current Assets | $592M | $688M | $970M | $2.1B | $2.2B |
| Property, Plant & Equip. | $5.9B | $5.2B | $4.2B | $2.4B | $2.4B |
| Goodwill & Intangibles | $4M | $4M | $2M | $2M | $2M |
| Long-Term Investments | $208K | $208K | $17M | $31M | $24M |
| Other Non-Current Assets | $208K | $208K | $0 | $0 | $9 |
| Total Non-Current Assets | $5.9B | $5.2B | $4.2B | $2.4B | $2.4B |
| Total Assets | $6.5B | $5.8B | $5.2B | $4.5B | $4.6B |
| — Liabilities — | |||||
| Accounts Payable | $1.2B | $1.2B | $904M | $1.2B | $1.1B |
| Short-Term Debt | $7.5B | $8.2B | $4.6B | $3.7B | $1.2B |
| Deferred Revenue | $92M | $119M | $0 | $0 | $37M |
| Other Current Liabilities | $2.6B | $3.2B | $2.8B | $104M | $1.6B |
| Total Current Liabilities | $12.0B | $13.5B | $8.4B | $6.5B | $4.6B |
| Long-Term Debt | $939M | $0 | $812M | $0 | $560M |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $8 |
| Total Non-Current Liabilities | $1.1B | $131M | $850M | $10M | $569M |
| Total Liabilities | $13.2B | $13.6B | $9.2B | $6.5B | $5.1B |
| — Equity — | |||||
| Common Stock | $891M | $891M | $891M | $891M | $1.7B |
| Retained Earnings | -$13.8B | -$15.2B | -$9.8B | -$8.8B | $0 |
| Accumulated OCI | $2.8B | $3.9B | $0 | $1.3B | $0 |
| Total Stockholders Equity | -$6.5B | -$7.5B | -$4.0B | -$2.0B | -$518M |
| Total Liabilities & Equity | $6.5B | $5.8B | $5.2B | $4.5B | $4.6B |
| — Key Metrics — | |||||
| Total Debt | $8.4B | $8.2B | $5.4B | $3.7B | $1.8B |
| Net Debt | $8.4B | $8.1B | $5.4B | $3.6B | $1.7B |
| Total Investments | $88M | $54M | $62M | $95M | $24M |